This webinar was presented live on Wednesday, October 11, 2017. Click below to watch on demand.
When it comes to news out of the U.S. government: one word could sum up what it means for the medical device industry: “uncertainty.”
It was true at the start of 2017. And it is even truer today.
The effort to repeal and replace the Affordable Care Act is dead for now, a permanent repeal of the medical device tax is unclear, and FDA fee hikes taking effect Oct. 1 could affect innovation in surprising ways. Meanwhile, major M&A deals continue, with Stryker making a $701 million fluorescence imaging technology play with its acquisition of Novadaq.